Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Debbie E Wright"'
Autor:
Jane Harper, Katherine J Adams, Giovanna Bossi, Debbie E Wright, Andrea R Stacey, Nicole Bedke, Ruth Martinez-Hague, Dan Blat, Laure Humbert, Hazel Buchanan, Gabrielle S Le Provost, Zoe Donnellan, Ricardo J Carreira, Samantha J Paston, Luise U Weigand, Martina Canestraro, Joseph P Sanderson, Sophie Botta Gordon-Smith, Kate L Lowe, Karolina A Rygiel, Alex S Powlesland, Annelise Vuidepot, Namir J Hassan, Brian J Cameron, Bent K Jakobsen, Joseph Dukes
Publikováno v:
PLoS ONE, Vol 13, Iss 10, p e0205491 (2018)
Robust preclinical testing is essential to predict clinical safety and efficacy and provide data to determine safe dose for first-in-man studies. There are a growing number of examples where the preclinical development of drugs failed to adequately p
Externí odkaz:
https://doaj.org/article/c3d7165394b5442098ed39f7073a5fbd
Autor:
Maria Busz, Linda Hibbert, Luke Williams, Elizabeth E. Evans, Karolina Lech, Joseph Dukes, Annelise Vuidepot, Vanessa L. Clark, Sarah K. Bailey, Alice Barkell, Bent K. Jakobsen, Kathy Hale, Michelle Teng, Debbie E. Wright, Alasdair Gunn
Publikováno v:
Cancer Immunology Research. 8:B44-B44
ImmTAC (Immune mobilizing monoclonal TCRs against cancer) molecules are a new class of bi-specific biologic that combine a T-cell receptor (TCR)-targeting system with an anti-CD3 effector function to activate highly potent and specific T-cell respons
Autor:
Debbie E. Wright, Bent K. Jakobsen, Tomasz Dobrzycki, Ruth Martinez-Hague, Luise U. Weigand, Ana Ribeiro, Nicole Bedke, Jane Harper, Sophie Botta Gordon-Smith, Samantha Paston, Laure Humbert, Dan Blat, Joseph Dukes, Andrea Stacey, Giovanna Bossi, Zoe Donellan, Martina Canestraro
Publikováno v:
Cancer Immunology Research. 7:A214-A214
Immune Mobilising Monoclonal TCRs Against Cancer (ImmTAC) molecules are a new class of bi-specific biologic specifically designed to recognize and eradicate cancer cells. ImmTAC molecules are composed of an affinity-enhanced T-cell receptor (TCR) fus
Publikováno v:
The Journal of General Virology
Gammaherpesviruses infect at least 90 % of the world's population. Infection control is difficult, in part because some fundamental features of host colonization remain unknown, for example whether normal latency establishment requires viral lytic fu
Publikováno v:
The Journal of General Virology
Antibody is an important antiviral defence. However, it is considered to do little against human gamma-herpesviruses, which establish predominantly latent infections regulated by T cells. One limitation on analysing these infections has been that lat
Autor:
Alan Tracey, Lucy Barr, Karen Holt, Stephen J. Trevanion, Bob Plumb, Daniel Leongamornlert, Paul Wray, Carol Churcher, J. C. Davis, Ruth Gilderthorp, Christine Lloyd, Adrienne Hunt, Michelle Smith, Britt Kilian, Martina Konantz, Jeff Almeida-King, Richard M. Clark, Nick Barker, Kirsty Ambridge, Susan J. Clark, Karen Oliver, Glen Threadgold, Yong Gu, Jane E. Loveland, David Lloyd, Guy Griffiths, Ronald H.A. Plasterk, Karen McLaren, Sarah Pelan, Sarah Nichol, Kenric Leung, Rebecca Woodmansey, Sharmin Begum, Cigdem Eser, Sophie Palmer, Jacqueline Brown, Ian M Sealy, James Torrance, J Lovell, John E. Collins, Sara Widaa, A M Kimberley, A Tromans, Richard Pandian, Judith Konantz, Maria Geisler, Carlos Torroja, N Sycamore, Sancha Martin, Darren Barker, Amanda Rapp, Monte Westerfield, Silke Rudolph-Geiger, Zemin Ning, José Afonso Guerra-Assunção, Clare Riddle, Rebecca Glithero, Daniel P. Kelly, Nicholas Matthews, Pieter J. de Jong, Nigel P. Carter, Camille Berthelot, Fengtang Yang, A K Babbage, Graham Clark, Andrea Berger, Robert Andrews, C Griffiths, Jennifer Harrow, Gerd Jörg Rauch, Steve Searle, J. M. Wallis, Christa Lanz, Ruby Banerjee, William Chow, Jan Hinnerk Vogel, Matthieu Muffato, David Elliott, Mathias Teucke, Derek L. Stemple, Debbie E. Wright, Deepa Manthravadi, Gavin K. Laird, Sarah Sims, M Mashreghi-Mohammadi, David S. Saunders, Lena Karotki, P Garner, Paul Heath, Jane Rogers, Ines Gehring, J Garnett, Charles Lee, Philip Howden, John H. Postlethwait, Robert Geisler, Sarah Donaldson, Elizabeth Langley, Claire Raisen, Katherine Auger, Javier Herrero, Beiyuan Fu, Carol Scott, Zübeyde Ersan-Ürün, Mario Caccamo, Sean Humphray, Gary L A Barker, S. Whitehead, Darren Ware, Baoli Zhu, Jianxiang Chi, Jonathan Wood, Nigel Fosker, Sarah McGuire, Stephan C. Schuster, Chris Clee, Martina Oberländer, Daria Gordon, Clare Murnane, Romke Koch, Emma Gray, Beverley J. Mortimore, Harminder Sehra, Joanna Collins, Hugues Roest Crollius, Kirsten McLay, Kerstin Howe, Lauren Dyer, Christopher Stevens, Andrew D. Ellington, Kazutoyo Osoegawa, Stuart McLaren, Christopher N. Johnson, Giselle Kerry, Helen Beasley, Georgios Panagiotidis, Christiane Nüsslein Volhard, Tina Eyre, Horst Geiger, Jennifer Yen, Matthew Ellwood, Christine P. Bird, N Corby, Matthew Dunn, Darren Grafham, Günter Raddatz, Matthew Humphries, Anette Kirn, Yi Zhou, James D. Cooper, John Burton, Simon D. M. White, Anton J. Enright, Dave Willey, Tim Hubbard, Rebekah Hall, Michael Kay, Matthew D. Clark, Matthew Jones, Glenn Harden, C. D. Skuce, Lauren Robertson, Leonard I. Zon, Lucy Matthews, Jeffrey C. Barrett, Michael A. Quail, Emma J. Kenyon, Leonor T. Quintais, Benjamin Phillimore, S Hammond, Carl Henderson, Joanna Harley, Elliot Harrison, Cordelia Langford, Christopher M. Dooley, Sean Maguire
Publikováno v:
Nature. 505:248-248
Nature 496, 498–503 (2013); doi:10.1038/nature12111 In this Letter, five authors were inadvertently omitted: Sharmin Begum and Christine Lloyd from the Wellcome Trust Sanger Institute, and Christa Lanz, Gunter Raddatz and Stephan C. Schuster from t
Autor:
Giovanna Bossi, Milos Aleksic, Peter L. Molloy, Deborah H. Sutton, Annelise Vuidepot, Rebecca Ashfield, Daniel Williams, Andrew K. Sewell, Naomi Harwood, Brian Cameron, Carl H. June, Frayne Bianchi, Tara Mahon, Yvonne McGrath, Anna Lissina, Penio Todorov, David Price, Samantha Paston, Rebecca Dennis, Alison Legg, Nick Pumphrey, Namir J. Hassan, Nathaniel Liddy, Katherine Adams, Jessie Gavarret, Jane Harper, Emma Gostik, Emma Baston, Michael Kalos, Debbie E. Wright, Andrew D. Johnson, Gabriela Pleas, Malkit Sami, Nikolai Lissin, Bent K. Jakobsen, Yi Li
Publikováno v:
Cancer Research. 71:4744-4744
In the last decade, major efforts in the fight against cancer have focused on galvanizing the adaptive immune system to kill tumors. Many of these endeavors are based on the development and clinical use of monoclonal antibodies (mAb) which are the mo
Autor:
Harper, Jane1, Adams, Katherine J.2, Bossi, Giovanna1, Wright, Debbie E.1, Stacey, Andrea R.1, Bedke, Nicole1, Martinez-Hague, Ruth1, Blat, Dan1, Humbert, Laure1, Buchanan, Hazel1, Le Provost, Gabrielle S.1, Donnellan, Zoe1, Carreira, Ricardo J.1, Paston, Samantha J.1, Weigand, Luise U.1, Canestraro, Martina1, Sanderson, Joseph P.2, Botta Gordon-Smith, Sophie1, Lowe, Kate L.1, Rygiel, Karolina A.1
Publikováno v:
PLoS ONE. 10/15/2018, Vol. 13 Issue 10, p1-19. 19p.